Question: Which of the following statements is false regarding the use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) in the elderly? These agents confer renal protection in patients with diabetes mellitus. Dose adjustment is not necessary in the presence of renal insufficiency. Avoid the use of these agents in the presence of renal artery stenosis. Hyperkalemia risk increases with concomitant use of an aldosterone antagonist.